CNY 30.51
(-0.46%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 2.64 Billion CNY | -44.05% |
2022 | 4.73 Billion CNY | 34.39% |
2021 | 3.52 Billion CNY | -30.94% |
2020 | 5.09 Billion CNY | 137.58% |
2019 | 2.14 Billion CNY | -60.61% |
2018 | 5.44 Billion CNY | 55.86% |
2017 | 3.49 Billion CNY | 152.19% |
2016 | 1.38 Billion CNY | -59.41% |
2015 | 3.41 Billion CNY | -8.53% |
2014 | 3.73 Billion CNY | -15.43% |
2013 | 4.41 Billion CNY | 34.77% |
2012 | 3.27 Billion CNY | 1307.92% |
2011 | 232.72 Million CNY | 66.23% |
2010 | 140 Million CNY | 55.56% |
2009 | 90 Million CNY | 800.0% |
2008 | 10 Million CNY | -72.22% |
2007 | 36 Million CNY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 1.29 Billion CNY | -51.04% |
2024 Q2 | 1.9 Billion CNY | 5.27% |
2024 Q3 | 888.95 Million CNY | -34.87% |
2023 Q4 | 2.64 Billion CNY | -27.49% |
2023 Q1 | 4.02 Billion CNY | -14.9% |
2023 FY | 2.64 Billion CNY | -44.05% |
2023 Q2 | 3.63 Billion CNY | -9.65% |
2023 Q3 | 3.65 Billion CNY | 0.37% |
2022 FY | 4.73 Billion CNY | 34.39% |
2022 Q4 | 4.73 Billion CNY | -11.99% |
2022 Q3 | 5.37 Billion CNY | -11.23% |
2022 Q2 | 6.05 Billion CNY | -6.26% |
2022 Q1 | 6.46 Billion CNY | 83.51% |
2021 Q1 | 4.62 Billion CNY | -9.27% |
2021 Q3 | 3.8 Billion CNY | -4.97% |
2021 Q4 | 3.52 Billion CNY | -7.35% |
2021 Q2 | 4 Billion CNY | -13.54% |
2021 FY | 3.52 Billion CNY | -30.94% |
2020 Q2 | 2.23 Billion CNY | -36.89% |
2020 Q4 | 5.09 Billion CNY | 0.97% |
2020 FY | 5.09 Billion CNY | 137.58% |
2020 Q3 | 5.05 Billion CNY | 126.43% |
2020 Q1 | 3.53 Billion CNY | 64.65% |
2019 Q2 | 5.42 Billion CNY | 25.24% |
2019 FY | 2.14 Billion CNY | -60.61% |
2019 Q1 | 4.33 Billion CNY | -20.46% |
2019 Q4 | 2.14 Billion CNY | -45.23% |
2019 Q3 | 3.91 Billion CNY | -27.8% |
2018 Q3 | 4.56 Billion CNY | 4.71% |
2018 Q4 | 5.44 Billion CNY | 19.47% |
2018 Q1 | 4.39 Billion CNY | 25.7% |
2018 Q2 | 4.35 Billion CNY | -0.88% |
2018 FY | 5.44 Billion CNY | 55.86% |
2017 Q2 | 1.04 Billion CNY | -2.74% |
2017 FY | 3.49 Billion CNY | 152.19% |
2017 Q4 | 3.49 Billion CNY | 15.14% |
2017 Q3 | 3.03 Billion CNY | 191.43% |
2017 Q1 | 1.07 Billion CNY | -22.73% |
2016 Q3 | 2.9 Billion CNY | 4.33% |
2016 Q4 | 1.38 Billion CNY | -52.23% |
2016 Q2 | 2.78 Billion CNY | -35.08% |
2016 FY | 1.38 Billion CNY | -59.41% |
2016 Q1 | 4.28 Billion CNY | 25.44% |
2015 Q1 | 2.86 Billion CNY | -23.32% |
2015 FY | 3.41 Billion CNY | -8.53% |
2015 Q3 | 2.66 Billion CNY | -7.91% |
2015 Q4 | 3.41 Billion CNY | 28.19% |
2015 Q2 | 2.89 Billion CNY | 1.06% |
2014 Q4 | 3.73 Billion CNY | -16.53% |
2014 Q3 | 4.47 Billion CNY | 0.07% |
2014 Q2 | 4.47 Billion CNY | 0.06% |
2014 FY | 3.73 Billion CNY | -15.43% |
2014 Q1 | 4.46 Billion CNY | 1.2% |
2013 FY | 4.41 Billion CNY | 34.77% |
2013 Q4 | 4.41 Billion CNY | -15.17% |
2013 Q3 | 5.2 Billion CNY | 19.33% |
2013 Q2 | 4.36 Billion CNY | -0.03% |
2013 Q1 | 4.36 Billion CNY | 33.17% |
2012 FY | 3.27 Billion CNY | 1307.92% |
2012 Q1 | 277.76 Million CNY | 19.35% |
2012 Q2 | 1.89 Billion CNY | 581.9% |
2012 Q3 | 1.86 Billion CNY | -1.6% |
2012 Q4 | 3.27 Billion CNY | 75.8% |
2011 Q1 | 190 Million CNY | 35.71% |
2011 FY | 232.72 Million CNY | 66.23% |
2011 Q3 | 240.98 Million CNY | 244.26% |
2011 Q4 | 232.72 Million CNY | -3.43% |
2011 Q2 | 70 Million CNY | -63.16% |
2010 Q2 | 90 Million CNY | 0.0% |
2010 Q1 | 90 Million CNY | 0.0% |
2010 Q3 | 90 Million CNY | 0.0% |
2010 Q4 | 140 Million CNY | 55.56% |
2010 FY | 140 Million CNY | 55.56% |
2009 FY | 90 Million CNY | 800.0% |
2009 Q4 | 90 Million CNY | 0.0% |
2008 FY | 10 Million CNY | -72.22% |
2007 FY | 36 Million CNY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Zhejiang Int'l Group Co.,Ltd. | 671.68 Million CNY | -294.322% |
Zhejiang Zhenyuan Share Co., Ltd. | 54.96 Million CNY | -4719.042% |
Hunan Jingfeng Pharmaceutical Co.,Ltd. | 94.96 Million CNY | -2688.917% |
Hubei Guangji Pharmaceutical Co., Ltd. | 419.53 Million CNY | -531.312% |
Yifan Pharmaceutical Co., Ltd. | 812.04 Million CNY | -226.164% |
Guangdong Jiaying Pharmaceutical Co., Ltd | - CNY | -Infinity% |
Chongqing Lummy Pharmaceutical Co., Ltd. | 126.5 Million CNY | -1993.745% |
Boai NKY Medical Holdings Ltd. | 32.61 Million CNY | -8020.888% |
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 21.25 Million CNY | -12360.356% |